glp-1 kidney protection Receptor Agonists and Diabetic Disease: A Call of Attention to Nephrologists GLP-1 receptor agonists and next-generation

The goal is to reduce side effects, improve tolerance, and lower treatment costs while still getting the metabolic benefits

GLP-1R/GIPR receptor activation in the brain also reduces appetite and promotes satiety, supporting development of liraglutide, semaglutide, and tirzepatide for weight loss

Second, glycolysis provides essential biosynthetic intermediates for the production of nucleotides, lipids, and amino acids, which are essential for myofibroblast proliferation and ECM synthesis [14]

Available from: 166.Dhatariya K., Levy N., Kilvert A., et al

[15] [16] Gastrointestinal symptoms may be misattributed to fatigue or may coexist with and contribute to tiredness